The evidence is now stronger than a mere signal. On SNY’s 3Q10 CC last week, COO Hanspeter Spek flat-out asserted that there will be no authorized generic as long as NVS/MNTA have the sole approved generic.
Thus, the implicit evidence from #msg-53738652 is now explicit.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.